Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Alpine Immune Sciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ALPN
Nasdaq
8731
https://www.alpineimmunesciences.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Alpine Immune Sciences Inc
Lyra Therapeutics (LYRA) Soars 6.5%: Is Further Upside Left in the Stock?
- Mar 28th, 2024 11:08 am
Alpine Immune Sciences Presents New Translational Data on Povetacicept at the European Lupus Meeting 2024
- Mar 21st, 2024 11:45 am
Alpine Immune Sciences to Participate in Upcoming H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
- Mar 20th, 2024 8:30 pm
Here's Why We're Not Too Worried About Alpine Immune Sciences' (NASDAQ:ALPN) Cash Burn Situation
- Mar 20th, 2024 11:27 am
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Q4 2023 Earnings Call Transcript
- Mar 19th, 2024 12:32 pm
Q4 2023 Alpine Immune Sciences Inc Earnings Call
- Mar 19th, 2024 10:48 am
Alpine Immune Sciences, Inc. (ALPN) Q4 Earnings and Revenues Beat Estimates
- Mar 18th, 2024 11:25 pm
Alpine Immune Sciences Inc (ALPN) Reports Full Year 2023 Financial Results
- Mar 18th, 2024 9:31 pm
Alpine Immune Sciences Provides Corporate Update and Full Year 2023 Financial Results
- Mar 18th, 2024 8:05 pm
Is a Surprise Coming for Alpine Immune Sciences (ALPN) This Earnings Season?
- Mar 14th, 2024 12:38 pm
Adobe (ADBE) to Report Q1 Earnings: What's in the Offing?
- Mar 11th, 2024 4:34 pm
Alpine Immune Sciences, Inc. (ALPN) Expected to Beat Earnings Estimates: Should You Buy?
- Mar 11th, 2024 2:00 pm
Alpine Immune Sciences to Report Fourth Quarter and Full Year 2023 Financial Results
- Mar 7th, 2024 9:30 pm
Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences
- Feb 26th, 2024 9:30 pm
Alpine Immune Sciences, Inc.'s (NASDAQ:ALPN) high institutional ownership speaks for itself as stock continues to impress, up 27% over last week
- Jan 28th, 2024 12:29 pm
Is Cybin Inc. (CYBN) Stock Outpacing Its Medical Peers This Year?
- Jan 11th, 2024 2:40 pm
Alpine Immune Sciences Announces Amendment of Acazicolcept Option and License Agreement with AbbVie
- Dec 21st, 2023 9:15 pm
Is Alpine Immune Sciences (ALPN) Stock Outpacing Its Medical Peers This Year?
- Dec 19th, 2023 2:50 pm
Alpine Immune Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Dec 18th, 2023 9:30 pm
Optimistic Investors Push Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares Up 41% But Growth Is Lacking
- Dec 18th, 2023 12:17 pm
Scroll